Honor Coleman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Honor Coleman has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Anne M. McIntosh
Epilepsy Research Centre, University of Melbourne, Melbourne, Victoria, Australia
6 shared publications - Genevieve Rayner
Department of Neurology Alfred Hospital Melbourne Victoria Australia
5 shared publications - Chris L. Peterson
La Trobe University
3 shared publications - Christine Walker
Epilepsy Foundation Canterbury, Victoria, Australia; Epilepsy Australia Canterbury, Victoria, Australia
3 shared publications - Piero Perucca
Department of Medicine (Austin Health) The University of Melbourne Melbourne Victoria Australia
3 shared publications - Sarah J. Wilson
Melbourne School of Psychological Sciences The University of Melbourne Melbourne Victoria Australia
3 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Wiley in Epilepsia Open
Early neurocognitive outcomes following SEEG with radiofrequency thermocoagulation
Objective: Characterization of early neuropsychological outcomes following SEEG with radiofrequency thermocoagulation (RFTHC) is essential to guide patient expectations around return to work, study, and caregiving. The current study aimed to describe the early neurocognitive sequelae of SEEG. Methods: Consecutive patients undergoing SEEG were prospectively recruited from two tertiary epilepsy centers in Melbourne, Australia. Patients were administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) via telehealth before and 3 weeks after SEEG ( M = 19.69 days, SD = 4.41). Given the telehealth platform, the coding subtest was substituted for the Symbol Digit Modalities Test, and a modified score of global cognitive function was calculated. To evaluate group changes, paired sample t ‐tests were performed. Reliable change indices were computed to explore individual‐level changes. Pearson's correlation coefficients evaluated relationships between change in global cognitive function and SEEG admission variables. SEEG patients were invited to complete a semi‐structured interview canvassing the recovery following SEEG. Results: Twenty‐eight patients completed the neuropsychological examination ( M = 37.89 years, SD = 9.72, range = 17–56 years, 54% female). All patients underwent RFTHC with a mean of 11.43 (SD = 6.87, range = 2–28) coagulation sites. At a whole group level, 3‐weeks post SEEG there was no evidence for global nor domain‐specific cognitive change. Reliable change indices with 90% confidence revealed only 4% (1/28) declined on at least two measures and 10% (3/28) showed psychometric improvement. Pearson's correlational coefficients showed no evidence for association between change in global cognitive function with SEEG factors including admission length, number of spontaneous or stimulated seizures, number of electrodes, or number of RFTHC sites. Subjective reports of language change tended to be accompanied by a decline on the RBANS language index that did not meet reliable change criteria. Most patients reported returning to work around 4 weeks post SEEG. Significance: By 3 weeks, gross cognitive functioning tends to be in keeping with pre‐SEEG performances for most patients. These findings have direct clinical implications for SEEG neuropsychological counseling. Plain Language Statement: SEEG is increasingly used to guide epilepsy surgery. Despite this, little is known about the cognitive recovery in the weeks following the procedure. We found that for most patients, broad cognitive functioning 3 weeks after SEEG with coagulation was consistent with function before SEEG, with only a small minority showing significant changes. Some people who reported language difficulties also showed a decline on language testing, although this was often small. Of those patients working before SEEG, most returned to work by 4 weeks. These results provide important evidence to guide patient counseling, recovery planning, and management after SEEG.
- 19 October 2026
- Published by Wiley in Epilepsia Open
Open AccessEarly neurocognitive outcomes following SEEG with radiofrequency thermocoagulation
Objective: Characterization of early neuropsychological outcomes following SEEG with radiofrequency thermocoagulation (RFTHC) is essential to guide patient expectations around return to work, study, and caregiving. The current study aimed to describe the early neurocognitive sequelae of SEEG. Methods: Consecutive patients undergoing SEEG were prospectively recruited from two tertiary epilepsy centers in Melbourne, Australia. Patients were administered the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) via telehealth before and 3 weeks after SEEG ( M = 19.69 days, SD = 4.41). Given the telehealth platform, the coding subtest was substituted for the Symbol Digit Modalities Test, and a modified score of global cognitive function was calculated. To evaluate group changes, paired sample t ‐tests were performed. Reliable change indices were computed to explore individual‐level changes. Pearson's correlation coefficients evaluated relationships between change in global cognitive function and SEEG admission variables. SEEG patients were invited to complete a semi‐structured interview canvassing the recovery following SEEG. Results: Twenty‐eight patients completed the neuropsychological examination ( M = 37.89 years, SD = 9.72, range = 17–56 years, 54% female). All patients underwent RFTHC with a mean of 11.43 (SD = 6.87, range = 2–28) coagulation sites. At a whole group level, 3‐weeks post SEEG there was no evidence for global nor domain‐specific cognitive change. Reliable change indices with 90% confidence revealed only 4% (1/28) declined on at least two measures and 10% (3/28) showed psychometric improvement. Pearson's correlational coefficients showed no evidence for association between change in global cognitive function with SEEG factors including admission length, number of spontaneous or stimulated seizures, number of electrodes, or number of RFTHC sites. Subjective reports of language change tended to be accompanied by a decline on the RBANS language index that did not meet reliable change criteria. Most patients reported returning to work around 4 weeks post SEEG. Significance: By 3 weeks, gross cognitive functioning tends to be in keeping with pre‐SEEG performances for most patients. These findings have direct clinical implications for SEEG neuropsychological counseling. Plain Language Statement: SEEG is increasingly used to guide epilepsy surgery. Despite this, little is known about the cognitive recovery in the weeks following the procedure. We found that for most patients, broad cognitive functioning 3 weeks after SEEG with coagulation was consistent with function before SEEG, with only a small minority showing significant changes. Some people who reported language difficulties also showed a decline on language testing, although this was often small. Of those patients working before SEEG, most returned to work by 4 weeks. These results provide important evidence to guide patient counseling, recovery planning, and management after SEEG.
- Open Access
- 12 September 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Mortality in two independent First Seizure Clinic cohorts up to 20 years post epilepsy diagnosis
- 12 September 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 185
Open AccessMortality in two independent First Seizure Clinic cohorts up to 20 years post epilepsy diagnosis
- 16 July 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 184, 111198
Socioeconomic status and time to epilepsy surgery in Australia: A retrospective tertiary centre cohort study
- 16 July 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 184, 111198
Socioeconomic status and time to epilepsy surgery in Australia: A retrospective tertiary centre cohort study
- 22 January 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 176, 110864
Delay to diagnosis of epilepsy: A history of a psychiatric disorder and substance use is associated with prior seizures
- 22 January 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 176, 110864
Delay to diagnosis of epilepsy: A history of a psychiatric disorder and substance use is associated with prior seizures
- 25 August 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110652
Drawing on a multi-disciplinary approach: art therapy to support patients through epilepsy surgery
- 25 August 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110652
Drawing on a multi-disciplinary approach: art therapy to support patients through epilepsy surgery
- Open Access
- 21 February 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 165, 110297
The lived experience of the burden of normality: Explored through the lens of art therapy
- 21 February 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 165, 110297
Open AccessThe lived experience of the burden of normality: Explored through the lens of art therapy
- Open Access
- 7 June 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 157, 109876
User experience of a seizure risk forecasting app: A mixed methods investigation
- 7 June 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 157, 109876
Open AccessUser experience of a seizure risk forecasting app: A mixed methods investigation
- Open Access
- 12 February 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (2) , 808-818
Comparative effectiveness of digital mental healthcare models for adults with epilepsy: A study protocol of a randomized controlled trial
Objective: Mental health complaints are prevalent among people with epilepsy, yet there are major barriers that prevent access to psychological care, including high out‐of‐pocket costs and a lack of accessible specialized services. The purpose of the current study is to examine the comparative efficacy, acceptability, cost‐effectiveness, and long‐term outcomes of a digital psychological intervention when delivered under two models of care (i.e., guided vs. unguided) in supporting the mental health and functioning of adults with epilepsy.Method: Approximately 375 participants across Australia will be enrolled. Eligible participants will have a confirmed diagnosis of epilepsy, experience difficulties with their emotional health, be at least 18 years of age, and live in Australia. Participants will be randomized (2:2:1) to receive the Wellbeing Neuro Course, a 10‐week internet‐delivered program, with (i.e., guided) or without guidance by a mental health clinician (i.e., unguided), or be allocated to a treatment‐as‐usual waiting‐list control group. Participants will complete online questionnaires at pre‐, post‐treatment, and 3‐ and 12‐month follow‐up and consent to have their data linked to their medical records to capture healthcare system resource use and costs.Analysis: Primary outcome measures will be symptoms of depression and anxiety. A cost‐utility analysis will be undertaken using the Australian healthcare system perspective and according to current economic evaluation guidelines. Resource use and costs to the healthcare system during the study period will be captured via data linkage to relevant administrative datasets in Australia.Significance: The results of this trial will provide important data concerning the relative outcomes of these different models of care and will inform the integration of digital psychological interventions translation into healthcare services.Ethics and Dissemination: The Human Research Ethics Committee of Macquarie University approved the proposed study (Reference No: 520231325151475). The results will be disseminated through peer‐reviewed publication(s).ANZCTR Trial Registration Number: ACTRN12623001327673.Plain Language Summary: This study seeks to find out if a 10‐week online psychological treatment can improve the mental health and well‐being of Australian adults with epilepsy. Around 375 participants will be randomly assigned to different groups: one will receive treatment with guidance from mental health clinician (guided group), one without guidance (unguided group), and one starting later (waiting control group). All participants will fill out the same outcome measures online. The main goal of this research is to compare these groups and assess how well the treatment works in improving mental health outcomes.
- 12 February 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (2) , 808-818
Open AccessComparative effectiveness of digital mental healthcare models for adults with epilepsy: A study protocol of a randomized controlled trial
Objective: Mental health complaints are prevalent among people with epilepsy, yet there are major barriers that prevent access to psychological care, including high out‐of‐pocket costs and a lack of accessible specialized services. The purpose of the current study is to examine the comparative efficacy, acceptability, cost‐effectiveness, and long‐term outcomes of a digital psychological intervention when delivered under two models of care (i.e., guided vs. unguided) in supporting the mental health and functioning of adults with epilepsy.Method: Approximately 375 participants across Australia will be enrolled. Eligible participants will have a confirmed diagnosis of epilepsy, experience difficulties with their emotional health, be at least 18 years of age, and live in Australia. Participants will be randomized (2:2:1) to receive the Wellbeing Neuro Course, a 10‐week internet‐delivered program, with (i.e., guided) or without guidance by a mental health clinician (i.e., unguided), or be allocated to a treatment‐as‐usual waiting‐list control group. Participants will complete online questionnaires at pre‐, post‐treatment, and 3‐ and 12‐month follow‐up and consent to have their data linked to their medical records to capture healthcare system resource use and costs.Analysis: Primary outcome measures will be symptoms of depression and anxiety. A cost‐utility analysis will be undertaken using the Australian healthcare system perspective and according to current economic evaluation guidelines. Resource use and costs to the healthcare system during the study period will be captured via data linkage to relevant administrative datasets in Australia.Significance: The results of this trial will provide important data concerning the relative outcomes of these different models of care and will inform the integration of digital psychological interventions translation into healthcare services.Ethics and Dissemination: The Human Research Ethics Committee of Macquarie University approved the proposed study (Reference No: 520231325151475). The results will be disseminated through peer‐reviewed publication(s).ANZCTR Trial Registration Number: ACTRN12623001327673.Plain Language Summary: This study seeks to find out if a 10‐week online psychological treatment can improve the mental health and well‐being of Australian adults with epilepsy. Around 375 participants will be randomly assigned to different groups: one will receive treatment with guidance from mental health clinician (guided group), one without guidance (unguided group), and one starting later (waiting control group). All participants will fill out the same outcome measures online. The main goal of this research is to compare these groups and assess how well the treatment works in improving mental health outcomes.
- Open Access
- 6 March 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 141, 109149
Body image dissatisfaction: A novel predictor of poor quality of life in epilepsy
- 6 March 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 141, 109149
Open AccessBody image dissatisfaction: A novel predictor of poor quality of life in epilepsy
“Do I still have epilepsy?” Epilepsy identity 15–20 years after anterior temporal lobectomy
Objective: Identity is a multifaceted construct, comprising personal identity (sense of being a unique individual) and social identity (the sense‐of‐self derived from membership of social groups). Social identity involves explicit identification with a group (“I am …”) and implicit behaviors or attitudes associated with group membership. Following successful treatment with surgery, patients with epilepsy can undergo a complex and lasting change in personal identity. To date, there has been no research into postoperative social epilepsy identity (SEI). We sought to examine SEI 15–20 years post‐surgery, and the relationship between SEI and satisfaction with surgery, psychosocial improvements, mood, and health‐related quality of life (HRQoL).Methods: Thirty‐two patients who underwent anterior temporal lobectomy (ATL; 19 female) were recruited, with a median follow‐up of 18 years (interquartile range [IQR] = 2.5). Using a novel interactive online program, we collected data on SEI, satisfaction with surgery, and perceived psychosocial improvements, alongside standardized measures of mood (Neurological Disorders Depressio Inventory‐Epilepsy; Patient Health Questionnaire‐Generalised Anxiety Disorder‐7 item) and HRQoL (Quality of Life in Epilepsy‐31 item). Non‐parametric analyses were used to analyse the data.Results: Twenty‐five percent of patients were free of disabling seizures since surgery, yet 65% stated they no longer had epilepsy and >90% reported satisfaction with surgery. Explicitly discarding SEI was positively associated with HRQoL at long‐term follow‐up, over and above seizure outcome. Implicit SEI was expressed as (a) acceptance of epilepsy, (b) a sense of belonging to the epilepsy community, and (c) difficulty disclosing and discussing epilepsy. Difficulty disclosing and discussing epilepsy was associated with increased anxiety and lower HRQoL.Significance: At long‐term follow‐up, over half of our patients reported an explicit change in SEI, which could promote better HRQoL. In contrast, difficulty with disclosure of epilepsy was associated with increased anxiety and reduced HRQoL, possibly reflecting the ongoing effects of stigma. These findings highlight the importance of understanding changes in patient social identity for promoting long‐term well‐being after surgery.
“Do I still have epilepsy?” Epilepsy identity 15–20 years after anterior temporal lobectomy
Objective: Identity is a multifaceted construct, comprising personal identity (sense of being a unique individual) and social identity (the sense‐of‐self derived from membership of social groups). Social identity involves explicit identification with a group (“I am …”) and implicit behaviors or attitudes associated with group membership. Following successful treatment with surgery, patients with epilepsy can undergo a complex and lasting change in personal identity. To date, there has been no research into postoperative social epilepsy identity (SEI). We sought to examine SEI 15–20 years post‐surgery, and the relationship between SEI and satisfaction with surgery, psychosocial improvements, mood, and health‐related quality of life (HRQoL).Methods: Thirty‐two patients who underwent anterior temporal lobectomy (ATL; 19 female) were recruited, with a median follow‐up of 18 years (interquartile range [IQR] = 2.5). Using a novel interactive online program, we collected data on SEI, satisfaction with surgery, and perceived psychosocial improvements, alongside standardized measures of mood (Neurological Disorders Depressio Inventory‐Epilepsy; Patient Health Questionnaire‐Generalised Anxiety Disorder‐7 item) and HRQoL (Quality of Life in Epilepsy‐31 item). Non‐parametric analyses were used to analyse the data.Results: Twenty‐five percent of patients were free of disabling seizures since surgery, yet 65% stated they no longer had epilepsy and >90% reported satisfaction with surgery. Explicitly discarding SEI was positively associated with HRQoL at long‐term follow‐up, over and above seizure outcome. Implicit SEI was expressed as (a) acceptance of epilepsy, (b) a sense of belonging to the epilepsy community, and (c) difficulty disclosing and discussing epilepsy. Difficulty disclosing and discussing epilepsy was associated with increased anxiety and lower HRQoL.Significance: At long‐term follow‐up, over half of our patients reported an explicit change in SEI, which could promote better HRQoL. In contrast, difficulty with disclosure of epilepsy was associated with increased anxiety and reduced HRQoL, possibly reflecting the ongoing effects of stigma. These findings highlight the importance of understanding changes in patient social identity for promoting long‐term well‐being after surgery.